Teplizumab (CD3) - Research Grid Biosimilar
Gecertificeerd

Teplizumab (CD3) - Research Grid Biosimilar

Catalog #: 11-015
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

This is anti-CD3 monoclonal antibody used to prevent or delay the development of clinical type 1 diabetes (T1D) in high-risk groups. High-risk groups refer to the presence of 2 or more T1D-related autoantibodies in the body.

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Neuroscience

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Other Product Names

MGA-031/MGA031; PRV-031

Beschrijving

Teplizumab (CD3) - Research Grid Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamTeplizumab (CD3) - Research Grid Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer11-015